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Summary
Background: Long term status of pulmonary tuberculosis (PTB) patients treated with short course chemotherapy (SCC)
regimens remains unknown.
Objective: To assess the clinical, bacteriological, radiological status and health related quality of life (HRQoL) of PTB
patients 14 -18 years after successful treatment with SCC.
Methodology: In a cross-sectional study, cured PTB patients treated during 1986 – 1990 at the Tuberculosis Research Centre
(TRC) were investigated for their current health status including pulmonary function tests (PFT). The St Georges respiratory
questionnaire (SGRQ) was used to assess the HRQoL
Results: The mean period after treatment completion for the 363 eligible participants was 16.5yrs (range 14-18 yrs, 84%
coverage) ; 25 (7 %) had been re-treated and 52 (14%) died. Among the investigated, 58 (29%) had persistent respiratory
symptoms; 170(86%) had radiological sequelae but none had active disease. Abnormal PFT was observed in 96 (65%) with
predominantly restrictive type of disease in 66(45%). The SGRQ scores for activity and impact were high implying
impairment in HRQoL.
Conclusion: Assessment of long term status of cured PTB patients showed an impairment of lung functions and HRQoL
highlighting the need to address these issues in the management of TB that may provide added value to patient care.
[Indian J Tuberc 2009; 56:132-140]
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INTRODUCTION
Standardised and directly observed six
month regimen is currently recommended for the
treatment of Pulmonary Tuberculosis (PTB). The
main objective of treatment in PTB is to achieve
high bacteriological cure rates. Though the patients
are cured of the disease, the information on the long
term status of the patients successfully treated with
short course chemotherapy (SCC) regimens remains
largely unknown. Studies have documented that
about 1/3rd  of the cured PTB patients do have
respiratory complaints at the end of treatment
seeking medical care1,2. The morbidity in PTB
patients while on treatment or at the end of treatment
has been reported using subjective (quality of life)
as well as objective (pulmonary function tests)
measurements1-7. However, the long term status of
cured PTB patients has not been studied. This
information is essential to quantify the impact of
disease for appropriate early interventions in the
management of patients with PTB. Hence the
Tuberculosis Research Centre (TRC) undertook a
study to assess the clinical, bacteriological and
radiological status of PTB patients14 -18 years after
successful completion of treatment with SCC .The
aim of the present communication is to analyze the
morbidity in these patients.
METHODOLOGY
Setting
TRC has been undertaking randomized
controlled clinical trials in the treatment of pulmonary
and extra-pulmonary forms of TB since 1956 with the
objective of evolving suitable chemotherapeutic
regimens in patients suffering from TB. The patients
enrolled in the trial are followed up bacteriologically
and radiologically for a maximum period of five years.
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Study population
This cross-sectional study was conducted
at TRC, Chennai, during August 2004 – 2005. The
study population included patients enrolled during
1986-1990 and had bacteriological quiescence (ie.
culture negative) at the 60th month of follow-up.
These were new PTB patients (<1 month of previous
anti-tuberculosis drugs) who were treated with first
line anti-tuberculosis drugs namely isoniazid (H),
rifampicin (R), pyrazinamide (Z) and ethambutol (E)
in one of the following SCC regimens which
included six month intermittent (2EHRZ2/4EHR2,
2HRZ2/4RH2) or nine month daily (2EHRZ/ 6EH)
regimens.
All efforts were made to interview the
patients during home visits or over the telephone.
In case of reported death of the patient, a doctor’s
visit was made to probe the reasons for death (verbal
autopsy)
When the patient attended the centre, a
detailed history which included re-treatment during
the follow-up period was elicited, after obtaining
informed consent. Information was also obtained
on habits which included smoking and alcoholism,
respiratory symptoms and co-morbid conditions like
diabetes, hypertension, bronchial asthma and cardiac
problem. The blood pressure, weight and height were
recorded and a general and systemic examination
was performed. Other investigations included
postero-anterior chest radiography, two sputum
examination by smear and culture for tubercle bacilli,
12 lead Electrocardiogram (ECG) and Pulmonary
function test (PFT) by Spirometry.  The quality of
life was assessed by a trained social worker using
the St. Georges respiratory questionnaire (SGRQ).
Bacteriology: Sputum smears were examined for
AFB by fluorescence microscopy.8 and the
specimens were processed by modified Petroff’s
method and cultured on the LJ medium.9 All
positive cultures were subjected to identification
tests for Mycobacterium tuberculosis and to drug
susceptibility tests using the minimal inhibitory
concentration method for isoniazid and
rifampicin10,11.
Radiology: The chest x-rays were read by a panel
of three doctors. The following observations were
recorded namely a) the extent of lung involvement
which was documented as unilateral or bilateral, b)
the number of zones involved (minimum one-zone
to maximum six -zones and c) presence or absence
of cavitation12.
Electrocardiogam (ECG):  A 12 lead ECG was
recorded for the patients and independently read by
the cardiologist. The criteria laid down by WHO
(1961) were used for the ECG based diagnosis of
cor-pulmonale13.
Pulmonary function testing (PFT) – PFT was
performed according to the techniques mentioned
in the operating manual of the spirometry
(sensormedix) with special reference to American
Thoracic society of Standardization of spirometry.14
The parameters measured in spirometry include
Forced Vital Capacity (FVC), Forced expiratory
volume in 1 second (FEV1), ratio of FEV1 to FVC
(FEV1%). For assessing chronic changes, the
observed values of FVC, FEV1, and FEV1% were
expressed as a percentage of the predicted values
by using the regression equation developed by
Vijayan15. Lung function impairments were classified
according to the above mentioned parameters as
normal/restrictive disease/obstructive disease/
combined disease14 .
St Georges respiratory questionnaire (SGRQ):
In the present study. SGRQ, a standardized, airways
disease specific respiratory questionnaire, was used
to measure health related quality of life (HRQoL)16,
17 This health status instrument consisting of 50 items
is grouped under three components namely
symptoms (8 items) which measures respiratory
symptoms, activity (16 items) which measures
impairment of mobility or physical activity and
impact (26 items) which measures the psychosocial
impact of disease). This tool has been validated for
use in chronic pulmonary diseases including TB in
many countries including India18-23. SGRQ scores
were calculated using score calculation algorithms
and missing data imputation recommended by its
developer (P.W. Jones, St Georges Hospital Medical
School, London, UK) Scores ranging from 0 to
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100 are calculated for each component, as well as a
total score which summarizes the responses to all
items. Higher scores correspond to worse health-
related quality of life.
Analysis
The data were analyzed using a statistical
software package (SPSS, version 13 for Windows;
Inc; Chicago IL). The SGRQ was scored with the
scoring calculator (Excel-based) provided with the
instrument. For each SGRQ scale, distribution
characteristics, the percentage of patients with
missing information and reliability estimates were
calculated. Analysis of variance and t-test were used
to compare SGRQ scores between groups defined
by functional characteristics.
RESULTS
There were 455 patients who were treated
between  1986-1990 and for the present study 92
were excluded since 63 were re-treated for relapse,
seven had defaulted, 20 died of non-tuberculous
cause and in two patients treatment was changed.
Hence 363 were eligible for the present study
(Figure). This included 163 and 200 patients who
were treated with daily and intermittent regimens of
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Investigated
54%Re-Rx for TB
7%
Death
14%
Migrated
16%
Unwilling to 
attend 
9%
Exclusions 
Relapse  : 63 
 
Default  :  7 
 
Non –TB Death  : 20 
 
Change of Rx : 2 
Patients eligible for 0- (14-18) yrs follow-up  
Current study population 
363 
No. of patients treated between 1986-90 with a 0-5 yr follow-up  
455 
Figure: Status of pulmonary TB patients treated with SCC after a period of 14-18 years (n = 363)
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SCC respectively. The mean period after treatment
completion for the 363 eligible participants was
16.5yrs (range 14-18 years).There were 59 (16%)
patients who had migrated and information is
available for the remaining, giving a coverage of
84%. There were 25 (7%) who had been re-treated
and 52 (14%) patients who had died. Among the
227 patients who were available, 198 (87%) attended
our centre for investigations to assess the current
health status.
Re-treatment: Among the 25 (7%) patients who
were retreated, two were re-treated for extra-
pulmonary TB (Brain tuberculoma, TB
lymphadenitis).
Mortality: A verbal autopsy of the 52 (14%) patients
who expired including five females revealed no deaths
due to active TB. The mean age of these patients at
the time of death was 50yrs. The cause of death
could be attributed to respiratory pathology in 15
(29%) patients as the history of events preceding
death were repeated attacks of cough and
breathlessness necessitating frequent hospitalization
or medications.
Profile of patients who were investigated: The
mean age of the 198 patients who were investigated
was 46yrs (range 27-73years). Majority 124 (63%)
were males among whom 50% were smokers.
(Table-1).
Clinical: Respiratory complaints were reported by
58 (29%) of the patients, mainly of frequent cough
and/or breathlessness.
Bacteriology: Sputum smear and culture negativity
was seen in 193 (97%) of the study participants.
Table 1. Characteristics of the patients who were investigated (n= 198)
 
Parameters    n         % 
Sex                                          Male 124       63 
 Habits                                       Smoking 
                                                   Alcohol 
  62        50 
  47        38 
Respiratory symptoms free  140       71 
Bacteriology        AFB smear negative 
                             M.tb culture negative 
193        97 
196        99 
Chest X-ray        Normal 
                            Abnormal 
                             Fibrosis 
                             Calcification 
                             Fibrosis & Calcification 
                             Others 
                             Zones          < 2 
                                                 >2 
  
  28        14 
170        86 
  62        36 
  41        24 
  59        35 
   8          5 
  71        42 
  99        58 
ECG   
                             Normal 
                             Cor-pulmonale 
                             Others 
                             Un co-operative 
160        81 
  21        11 
  13          6 
    4          2 
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Among the five patients who had positive smears,
three patients were culture negative while two
patients’ cultures grew Mycobacterium kansasii.
Radiology: There were 28 (14%) patients with
normal chest radiography while others had
abnormality predominantly of fibrosis and or
calcification.
Spirometry: The pulmonary function tests were
performed in 148 (75%) patients who were willing
to participate which included 98 males and 50
females (Table-2). The spirometry was normal for
52 (35%) of the participants. The predominant lung
function impairment was restrictive type of disease
in 66 (45%) patients and this was observed more in
females - 32 (64%). Obstructive and combined type
of lung function impairments were predominant in
males. The difference in lung function impairments
between the smokers and non-smokers was not
statistically significant.
Electrocardiogram (ECG): Features suggestive of
cor-pulmonale was observed in 21(11%) of the
patients. The abnormal ECG changes observed in
the remaining 14(7%) patients were that of left
ventricular hypertrophy or heart rate disturbances
like sinus bradycardia or tachycardia.
SGRQ: Tables 3 and 4 describe mean SGRQ scale
scores in study population according to sex, smoking
behaviour, ECG, chest X-ray and FEV1% predicted.
Table 2: Types of abnormality in lung function in 148 investigated patients treated 14-18 years ago
with SCC
Table 3: Distribution characteristics and reliability estimates SGRQ scales in the study population
weighted sample (n=198)
 
 Symptoms Activity Impact Overall 
Mean Normal values* 
 
12 9 
 
2 
 
6 
 
Mean observed values 16.46 28.95 14.11 19.60 
SD 18.63 23.19 23.96 20.65 
Observed range 0-79.53 0-100 0-92.5 0-83.65 
% with missing data 1.5 3.1 4.6 5.1 
* Reference No: 26
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Males Females Total  
Type of disease n        % n        % n        % 
Normal  
Restrictive disease             
Obstructive disease  
Combined disease        
37          38 
34         35  
7            7  
20         20  
15       30 
32       64  
0         0 
3         6 
52    35 
66    45 
7     5 
23    16 
           Total        98        100         50    100  148    100 
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The mean SGRQ scores for symptom, activity and
impact including overall scores were high (increased
impairment) among this group of patients as
compared to that of general population. The overall
scores were significantly higher for females
(p=0.01) and smokers (p=0.03). However, abnormal
chest X-ray, ECG and FEV1% predicted did not
correlate significantly with high SGRQ scores.
The above mentioned clinical,
bacteriological, radiological, spirometry and ECG
findings were not different from those who were
treated with daily or intermittent SCC regimens.
DISCUSSION
To our knowledge, this study is the first of
its kind to assess the long term status of PTB
patients, 14-18 years after treatment with SCC
regimens. There were 58 (29%) participants who
had persistent respiratory symptoms and 170 (86%)
with radiological sequelae. Lung functions
impairments were present in 96 (65%) while ECG
showed evidence of cor-pulmonale in 21(11%).
Thus majority of the cured PTB patients had
significant morbidity as evidenced by impairment in
pulmonary functions and high SGRQ scores. This
Table 4: Mean SGRQ scale scores by demographical and clinical characteristics of the study
population.
 Symptom Activity Impact Overall 
Mean Normal values* 
 
12 9 
 
2 
 
6 
 
Sex                              Male 
                                 Female 
                                 p value 
15.10 
18.78 
NS 
24.55 
36.27 
0.001 
10.95 
19.24 
0.03 
16.43 
24.72 
0.01 
Male                       Smoker 
                       Non-smoker 
                               p value 
19.63 
11.45 
0.02 
30.37 
19.98 
0.02 
14.56 
8.07 
NS 
21.00 
12.85 
0.03 
Chest                  Abnormal 
Radiography         Normal 
                               p value 
17.46 
10.58 
0.01 
28.72 
30.29 
NS 
15.05 
8.79 
NS 
20.23 
16.12 
NS 
No. of zones involved   < 2 
Chest  radiography       >2 
                                 p value 
15.07 
17.90 
NS 
29.34 
28.56 
NS 
12.76 
15.46 
NS 
19.03 
20.17 
NS 
ECG                    Abnormal 
                              Normal 
                               p value 
20.85 
15.31 
NS 
36.36 
27.34 
0.03 
21.08 
12.19 
NS 
26.17 
17.89 
NS 
PFT  (n= 148) 
FEV1 %       <80%  
predicted      >80%                
                            p value 
 
19.35 
15.06 
NS 
 
28.98 
28.15 
NS 
 
14.10 
13.28 
NS 
 
19.97 
18.57 
NS 
* Reference No: 26 
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study highlights the presence of respiratory system
related morbidity among the microbiologically cured
PTB patients.
Persistent respiratory symptoms observed
in approximately 1/3rd of the patients in the present
study is an important cause of concern. Studies have
documented that cured PTB patients continue to have
respiratory symptoms (30-47%) at the end of
treatment, (40%) after one year of treatment and
(15.9%) after  two and a half years after
treatment1,2,5,24  In another study 14% of treated PTB
patients continued to attend the out-patient
department for more than five years for respiratory
complaints.25 Since all the investigated patients in the
present study were culture negative for
Mycobacterium tuberculosis, there is a need to
educate the patients that persistence of symptoms
is not synonymous with  reactivation  of the disease.
The respiratory disease specific SGRQ
scores were higher in this cohort of patients which
implies an impairment in the quality of life which is
in conformity with other studies done among PTB
patients18,19. As data pertaining to SGRQ scores in
general population in India is not available, the
normative values for a general population studied in
Spain recommended in SGRQ manual is used for
comparison. The symptom, activity and impact
scores observed in our study after a mean period of
16.5 years after successful treatment for TB were
16, 28 and 14 respectively as compared to general
population scores of 12, nine and two on a scale of
10026. These findings suggest that the scores of the
treated PTB patients were high (indicating worse
status) when compared to the general population.
Similar to earlier SGRQ studies in PTB patients, the
score for impact was lower than that of symptom
and activity18,19  The scores were less when
compared to patients with other respiratory diseases
like interstitial lung disease, COPD or
bronchiectasis20,21,22. These findings suggest that
HRQoL among  treated PTB patients was suboptimal
when compared to the general population, but better
when compared to other respiratory diseases.
Generally the observed SGRQ scores are
higher for females27. In this cohort the female
participants had a significantly higher scores in
SGRQ suggestive of impairment of HRQoL with
reference to activity and impact of disease as
compared to males. An earlier study done on PTB
patients while on treatment showed no gender
differences in the SGRQ scores18. Among the
males, in smokers SGRQ showed significant
impairment of quality of life emphasizing the need
to create an awareness about smoking cessation
among treated TB patients.
Lung function impairments after TB is an
unrecognized cause of chronic lung disease
worldwide7. In the present study PFT was done
in 75% of the patients. The predominant lung
function patterns observed in these patients were
restrictive and combined type similar to other
published studies6,7. Our findings, similar to a
previous reports have shown that females had
more restrictive type of disease compared to
males3. A previous study among treated PTB
patients from our centre showed that the main
ventilatory type of abnormality was restrictive in
nature  where as a study from Pretoria concluded
that equal number of patients had restrictive/
obstructive type of disease6,28. However, a study
from South Africa which was done at an average
of 16 years after TB treatment showed that 68%
of the patients had chronic obstructive lung
disease29. Impairments in lung function in the
present study were not significantly high among
smokers. The published studies on smoking and
lung function impairments in PTB patients are
varied19,30. The patients with a FEV1% Pred. of
<80% had high SGRQ scores implying poor
quality of life though it did not attain statistical
significance
We observed a mortality of 14% in this
cohort of patients. A study done among PTB
patients irrespective of being treated has shown a
mortality rate of 24% and lung function
impairment as the probable cause of death in 15%
after a duration of 10 years30. Although 15 patients
in our study had frequent respiratory complaints
or hospitalization among those who expired, it was
not possible to conclude that TB sequelae was
the probable cause of death.
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The high coverage observed in our study
could be attributed to the stringent efforts in
screening for domiciliary stability for enrollment of
patients to our controlled clinical trials. We observed
no difference in the profile of patients treated with
daily or intermittent anti-tuberculosis therapy. This
highlights the fact that intermittent chemotherapy is
as effective as daily pertaining to the long term
impact of pulmonary TB.
The major limitation of this study is that
the observations made need not be confined to TB
sequelae alone and could be due to the aging and or
health related factors of the study population. The
lack of concurrent age-sex matched controls coupled
with the lack of baseline investigations for pulmonary
functions and assessment of quality of life is also
another major limitation.
Despite the above mentioned limitations,
this study has shown that treated and cured PTB
patients do suffer from long term morbidity. India
is a high burden country for TB and there is an
active and well structured Revised National TB
Control Programme (RNTCP) operating
successfully covering the entire population since
March 2006.  The RNTCP has treated more than
8.1 million patients, and thereby prevented almost
1.46 million TB deaths.31 As the programme matures,
its level of sophistication will undoubtedly increase.1
From the findings of this study it appears that
the providers and programme managers have a
responsibility to recognize and address the long
term impact of TB even after patients are cured.
Addressing issues relevant to the quality of life
and considering measures for pulmonary
rehabilitation will provide added value to the
programme.
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